Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapy

BACKGROUND: We investigated the prognostic predictive value of the combination of fluorodeoxyglucose (FDG)- and fluoromisonidazole (FMISO)-PET in patients with non-small cell lung carcinoma (NSCLC) treated with stereotactic body radiation therapy (SBRT). PATIENTS AND METHODS: We prospectively examin...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Shiro, Inoue, Tetsuya, Okamoto, Shozo, Magota, Keiichi, Takayanagi, Ayumi, Sakakibara-Konishi, Jun, Katoh, Norio, Hirata, Kenji, Manabe, Osamu, Toyonaga, Takuya, Kuge, Yuji, Shirato, Hiroki, Tamaki, Nagara, Shiga, Tohru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892988/
https://www.ncbi.nlm.nih.gov/pubmed/31802264
http://dx.doi.org/10.1186/s13550-019-0578-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892988/
https://www.ncbi.nlm.nih.gov/pubmed/31802264
http://dx.doi.org/10.1186/s13550-019-0578-6

Ejemplares similares